Manjola U. Van Alphen, MD, PhD, MBA

  • 4Articles
  • 63.7KReads
  • 2022–2023Active
  • 10Collaborators
  • 7Citations

About

Manjola U. Van Alphen, MD, PhD, MBA, is affiliated with the Department of Psychiatry at Massachusetts General Hospital and Harvard Medical School. Van Alphen has published on clinical topics including addiction, neurology, and schizophrenia/schizoaffective disorders, with articles addressing drug-induced abnormal involuntary movements, agitation and altered mental status in emergency settings, smoking cessation facilitation in primary care, and clozapine management in primary care. The author has collaborated frequently with Chirag M. Vyas, Shreedhar Paudel, Theodore A. Stern, Abigail L. Donovan, and Aldis Petriceks.

Publications

PCC
Drug-Induced Abnormal Involuntary Movements
Rounds in the General Hospital

Drug-Induced Abnormal Involuntary Movements

May 11, 2023

Treatment of involuntary movements is based on their underlying etiology; however, symptomatic treatments are indicated to reduce motoric and psychological symptoms that impair social function and worsen quality of...
, , , et al
PCC
Agitation and an Altered Mental Status in the ED
Rounds in the General Hospital

Agitation and an Altered Mental Status in the ED

December 8, 2022

Mr A was brought to the ED by police due to increasingly irritable and disturbing behavior for the last month. This Rounds report provides guidance on managing altered mental...
, , , et al
PCC
Facilitating Smoking Cessation in Primary Care
Rounds in the General Hospital

Facilitating Smoking Cessation in Primary Care

May 17, 2022

Here, the authors discuss the importance of tobacco cessation, best practices involving pharmacologic agents and counseling techniques, and strategies to address myths related to smoking cessation.
, , , et al
PCC
Managing Clozapine in Primary Care
Rounds in the General Hospital

Managing Clozapine in Primary Care

February 17, 2022

In this article, gain insight into the management of patients taking clozapine. The authors also provide critical steps for early detection and management of life-threatening complications of clozapine, including...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe